Expansion of Diagnostic Portfolio VivaChek's diverse product range, including blood glucose monitors, blood ketone meters, lactate analyzers, and comprehensive POCT solutions like PCR and immunoassays, presents multiple entry points for upselling or cross-selling complementary diagnostic tools to healthcare providers and laboratories.

Recent Market Launches The launch of the VivaDiag antigen test in late 2020 demonstrates the company's capacity for rapid innovation in infectious disease diagnostics, opening opportunities to supply related rapid testing solutions and to partner with entities focusing on pandemic response or point-of-care testing expansion.

Growing Revenue Base With an estimated revenue between $10 million and $25 million and recent funding of $14 million, VivaChek is financially positioned to invest in sales initiatives, expand distribution channels, and increase market penetration in China and potentially internationally.

Focus on Precision Healthcare VivaChek’s emphasis on accuracy and reliability in its biosensors and POCT products aligns with increasing demand for high-quality diagnostics, making it attractive to healthcare providers seeking reliable rapid test solutions and continuous monitoring devices.

Strategic Location & Digital Presence Located in Hangzhou, China, with a strong digital infrastructure including Alibaba Cloud and a professional website, VivaChek has the regional presence and online assets to support targeted marketing campaigns and expand relationships with healthcare institutions domestically and abroad.